《广州医药》
点击关注官方服务号追踪稿件状态

【重要服务提醒】《广州医药》杂志服务号已上线稿件查询功能

各位作者、审稿专家:
本刊官方微信服务号新增稿件状态查询服务,无需反复登录投稿系统,微信即可随时查看审稿进度、修回通知、录用结果,稿件更新实时推送提醒,同步接收期刊征稿、学术资讯。

操作方式

微信搜索关注广州医药杂志服务号 → 点击菜单栏「绑定账号」→ 输入投稿邮箱完成账号关联;请关闭微信消息免打扰,避免遗漏稿件通知。

《广州医药》编辑部

广州医药杂志服务号
论著

PCV中吸气流速对OLV患者呼吸功能及炎症因子的影响

Effects of different inspiratory velocity during pressure-controlled ventilation on respiratory function and inflammatory factors in patients with one-lung ventilation

:38-45
 
目的 比较压力控制通气(PCV)中不同吸气流速对单肺通气(OLV)患者呼吸功能及炎症因子的影响。方法 本研究为2018—2019年对75例单肺通气患者的前瞻性研究。患者在麻醉和单肺通气(OLV)后随机分为吸气流量30 L/min(A组)、50 L/min(B组)或70 L/min(C组)。比较OLV前(T0)、OLV后30 min(T1)、60 min(T2)和120 min(T3)的呼吸力学、呼吸功能、血流动力学和血气分析,中心静脉血检测分析IL- 6、IL-8、TNF-α和sICAM-1,观察术后3天肺部并发症和ARDS的发生情况。结果 三组一般情况、血流动力学指标差异均无统计学意义(P>0.05);B组、C组PaCO2较A组降低(P<0.05);与T0时比较,T1-T3时三组PaO2、SVO2均降低(P<0.05);三组PH、SO2和HB差异均无统计学意义(P>0.05)。与A组比较,B组、C组ΔVT增大(P<0.05);三组Ppeak差异无统计学意义;与A组比较,B组、C组PEEP均增大(P<0.05);与A组比较,T1-T3时B组、C组VD/VT减少(P>0.05);与T0比较,T1-T3时三组Qs/Qt增加(P<0.05);与A组比较,T1-T3时B组、C组Cdyn增大(P<0.05);与T0相比,T1-T3时三组PaO2/FiO2降低(P<0.05);与T0相比,T1-T3时三组IL-6、IL-8、TNF-α和sICAM-1的浓度增多(P<0.05),但A组、B组低于C组(P<0.05)。三组患者发生术后肺部并发症和ARDS差异均无统计学意义。结论 在PCV模式下通过增加吸气流速能增加VT,减少死腔率,促进 CO2的交换,并且改善肺动态顺应性,但并不能很好的改善氧合及肺内分流。吸气流速50 mL/L在较小炎症反应的情况下达到上述改善呼吸功能和呼吸力学,可推荐应用于进行OLV患者。
Objective The effects of different inspiratory velocity PCV on respiratory function and inflammatory factors in patients with one-lung ventilation OLV were compared. Methods This was a prospective study of 75 patients with one-lung ventilation in 2018-2019. The subjects were randomized to the inspiratory velocity 30(group A),50(group B)or 70(group C)L/min after anesthesia and one-lung ventilation OLV. Respiratory mechanics,respiratory function,hemodynamics and blood gas parameters were compared between the three groups pre-OLV(T0)and after 30 (T1), 60 (T2), and 120 (T3)minutes of OLV.Center venous blood was collected to measure interleukin (IL)-6, IL-8,tumor necrosis factor (TNF)-α,andsoluble intercellular adhesion molecule-1 levels.Observation of pulmonary complications and occurrence of ARDS 3 days after operation were made. Results Hemodynamic and general patient status were similar between the three groups (all P>0.05). PaCO2was lower in the group B and group C compared with the group A (P<0.05). Compared with T0, PaO2 and SVO2were lower at T1-T3of the three groups(P<0.05). PH, SO2 and HB were similar between the three groups (all P>0.05).ΔVT was higher in the group B and group C compared with the group A (P<0.05);Ppeak were similar between the three groups (all P>0.05). PEEP was higher in the group B and group C compared with the group A (P<0.05); VD/VT decreased in the group B and group C compared with the group A (P<0.05).Compared with T0,Qs/Qt increased at T1-T3 of the three groups (all P<0.05). Cdyn increased at T1-T3 of the group B and group C(all P<0.05). PaO2/FiO2 decreased at T1-T3 of the three groups(all P<0.05).Compared with T0, the concentrations of Il-6, Il-8, TNF-α and sICAM-1 increased at T1-T3of three groups (P<0.05), and in group A and group B were lower than those in group C (P<0.05).The number of patients who had postoperative pulmonary complications PPCS or acute respiratory distress syndrome(ARDS)were similar between the three groups (all P>0.05). Conclusion In PCV mode, it can increase VT by increasing the inspiratory velocity, reduce the VD/VT, promote the exchange of CO2, and increase the Cdyn, but it cannot improve the oxygenation and Qs/Qt.Inspiratory velocity of 50 mL/L to achieve the above improvement in respiratory function and respiratory mechanics in the case of a smaller inflammatory response. It may be recommended for use in patients undergoing OLV.
论著

细胞毒素-1对人卵巢癌细胞体外增殖、凋亡的影响

Effect of cytotoxin-1 on human ovarian cancer cell proliferation and apoptosis in vitro

:24-27
 
目的 探讨细胞毒素-1(Cytotoxin-1,CTX-1)对人卵巢癌SKOV-3细胞增殖凋亡的影响。方法 利用0、4、8、12 μg/mL浓度 CTX-1处理SKOV-3细胞6、12、24 h,MTS法检测细胞活性,8 μg/mL CTX-1处理SKOV-3细胞24、48 h,Hoechst-33258荧光染色观察细胞核染色质形态。取处理 6、12 h 后细胞,利用流式细胞仪检测SKOV-3细胞的凋亡率。结果 4、8、12 μg/mL的CTX-1可抑制SKOV-3细胞活性及增殖,呈时间-剂量依赖。Hoechst-33258染色观察可见细胞染色质呈固缩或碎裂状、染色质着色不均、核形态各异,随时间增加而更趋明显。8 μg/mL CTX-1处理细胞,6 h细胞坏死率为(1.90±0. 27)%,晚期凋亡率为(10.96±1. 56)%,而早期凋亡率为(1.52±0.39)%;12 h细胞坏死率为(10.62±0.96)%,晚期凋亡率(15.07±1.23)%,而早期凋亡率为(1.88±0.17)%,与对照组比较,差异有统计学意义 (P<0.0 1)。结论 CTX-1可以抑制人卵巢癌细胞活性、抑制其体外增殖、诱导其发生凋亡,该作用呈剂量依赖和时间依赖,主要引起细胞晚期凋亡和坏死。
Objective To investigate the effect of cytotoxin-1 (CTX-1)on the proliferation and apoptosis of ovarian cancer SKOV-3 cells. Methods SKOV-3 cells were treated with CTX-1 at concentrations of 0, 4, 8, 12 μg/mL for 6, 12, and 24 hours respectively. Cell viability was measured by MTS method. SKOV-3 cells were treated with 8 μg/mL CTX-1 for 24 and 48 hours, by Hoechst-33258 fluorescence staining to observe the morphology of nuclear chromatin. The apoptotic rate of SKOV-3 cells was detected by flow cytometry after 6 and 12 hours of treatment. Results CTX-1 at 4, 8, and 12 μg/mL inhibited the activity and proliferation of SKOV-3 cells in a time-dose-dependent manner. Hoechst-33258 staining observation showed that the apoptotic cell chromatin was condensed or fragmented chromatin, the chromatin was unevenly colored, and the nuclear morphology was different. It became more obvious with time. 8 μg/mL CTX-1 treated cells, the 6 h cell necrosis rate was (1.90±0.27)%, the late apoptosis rate was (10.96±1.56)%, and the early apoptosis rate was (1.52±0.39)%; 12 hours cell necrosis rate was (10.62±0.96)%, late apoptosis rate was (15.07±1.23)%, and early apoptosis rate was (1.88±0.17)%, compared with the control group, the difference was statistically significant (P<0.01). Conclusion CTX-1 may inhibit the activity of human ovarian cancer cells, inhibit its proliferation in vitro, and induce its apoptosis. The effect is dose-dependent and time-dependent. Mainly it causes late apoptosis and necrosis of cells.
论著

iTRAQ联合质谱技术筛选COPD大鼠肺组织差异表达蛋白

Screening of differentially expressed proteins in the lung of COPD rats by iTRAQ and mass spectrometry

:6-10
 
目的 应用iTRAQ联合质谱技术筛选COPD大鼠肺组织差异表达蛋白。方法 20只雄性SD大鼠(200~220 g),随机分为对照组和模型组,每组10只,采用熏烟法建立COPD大鼠模型。观察大鼠肺组织病理学改变,测定肺功能,BALF白细胞数,肺组织总蛋白iTRAQ标记后质谱鉴定,用生物信息学方法分析蛋白表达变化。结果 与对照组相比,模型组大鼠支气管黏膜下肌层增厚,肺内可见大量炎性细胞浸润,肺功能降低,BALF白细胞数升高(均P<0.05)。质谱鉴定出4 916种蛋白,筛选出468个差异表达蛋白,其中285个表达上调,183个表达下调。筛选了上皮细胞粘着连接蛋白、fMLP、整合素等与COPD相关蛋白。结论 基于iTRAQ技术的蛋白质组学方法筛选出COPD大鼠差异表达蛋白,为进一步研究COPD的发生机制奠定了基础。
Objective iTRAQ and mass spectrometry were used to screen the differentially expressed proteins in the lung of COPD rats. Methods 20 male SD rats (200-220g)were randomly divided into control group and treatment group, with 10 rats in each group. COPD rat model was established by smoking. The lung function, the number of BALF leukocytes, the total protein iTRAQ in lung tissue were measured and identified by mass spectrometry. The differentially expressed proteins were identified by bioinformatic analysis. Results Compared with the control group, the submucous layer of bronchus in the model group was thickened, a large number of inflammatory cells were seen in the lung, the lung function was reduced, and the number of BALF leukocytes was increased. 4 916 proteins were identified by mass spectrometry, 468 differentially expressed proteins were screened, 285 of which were up-regulated and 183 down regulated. Among them, the important COPD related proteins were epithelial adhesion connexin, fMLP and integrins. Conclusion iTRAQ technology screened out the differentially expressed proteins of COPD rats, which laid the foundation for the further study of COPD mechanism
论著

高脂血症大鼠血液中氨基酸代谢标志物分析

Preliminary study on amino acid metabolism markers in blood of hyperlipidemia rats

:1-5
 
目的 探讨高脂血症大鼠模型前后血液中氨基酸代谢谱的变化,寻找高脂血症大鼠血液中氨基酸代谢标志物。方法 将SD大鼠随机分为正常对照组、模型组,连续灌胃给药4周后收集大鼠血液,测定各组大鼠血清中TG、TC、HDL-C、LDL-C含量,并运用超高效液相色谱-四极杆-飞行时间质谱(UPLC-Q-TOF-MS/MS)法测定血清中氨基酸代谢谱,利用统计学分析研究不同组动物间的氨基酸代谢的差异。结果 与正常对照组比较,模型组TG、TC、LDL-C含量升高,HDL-C含量降低,高脂血症大鼠模型建模成功;与正常对照组比较,模型组蛋氨酸、苯丙氨酸、脯氨酸、苏氨酸、缬氨酸、甘氨酸等6种氨基酸发生明显改变(P<0.05)。结论 高脂血症大鼠存在氨基酸代谢的紊乱,其中蛋氨酸、苯丙氨酸、脯氨酸、苏氨酸、缬氨酸、甘氨酸等6种氨基酸为其潜在的生物标志物。
Objective To investigate the amino acid metabolism profiles changes in the serum of SD rats, and identify the potential biomarkers. Methods SD rats were divided into normal group and model group. The contents of TG, TC, HDL-C, and LDL-C in the serum of each group were measured, after 4 weeks of continuous intragastric administration. Ultra performance liquid chromatography coupled with electrospray time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS/MS)was used to determine amino acid metabolism profile in serum, and statistical analysis was applied to determine metabolic differences among different groups of rats. Results As compared with normal group, TG, TC, LDL-C were increased and HDL-C was decreased in model group, hyperlipidemia rat model successfully modeled. As compared with normal group, methionine, phenylalanine, proline, threonine, valine, glycine in the amino acid metabolic profiling were decreased in model group (P<0.05). Conclusion Hyperlipidemia rats have disorders of amino acid metabolism, of which methionine, phenylalanine, proline, threonine, valine, and glycine are potential biomarkers.
论著

重组人血管内皮抑素联合化疗治疗晚期非小细胞肺癌的效果

Curative effect of recombinant human vascular endostatin combined with chemotherapy on advanced nonsmall cell lung cancer

:72-75
 
目的 观察重组人血管内皮抑素注射液(恩度) 联合化疗治非小细胞肺癌(NSCLC)的近期疗效和安全性。方法 对2015年3月—2017年10月经病理组织学或细胞学检查确诊的Ⅲ-Ⅳ期NSCLC74例患者,采用随机数字法把受试者随机分为联合治疗组(n=35)和对照组(n=39),联合治疗组接受恩度联合化疗的方案治疗;对照组单纯行常规化疗治疗。近期疗效评价采用RECIST标准,生活质量(QOL)采用Karnofsky评分(KPS),抗癌药物急性与亚急性毒性反应分度标准分0~Ⅳ度。比较两组患者的近期疗效指标(疾病完全缓解(CR)、疾病稳定( SD)、疾病进展( PD)、客观有效率(RR)、疾病控制率(DCR );QOL评分及毒副反应情况。结果 联合治疗组近期疗效指标RR及DCR高于对照组(P < 0.05);联合治疗组KPS评分高于对照组(P < 0.05);两组间的毒副作用包括恶心/呕吐、腹泻、疲乏、脱发、血小板下降及白细胞下降等,两组间毒副反应出现数量比较,差异无统计学意义(P > 0.05)。结论 恩度与化疗药物联合使用可以提高NSCLC疗效和改善患者生活质量,未增加患者不良反应发生率。
Objective To observe the curative effect and the side effects of recombinant human vascular endostatin (Endostar) combined with the chemotherapy on nonsmall cell lung cancer(NSCLC). Methods Seventy-four NSCLC patients confirmed by histopathology or cytopathology were randomly distributed to combined therapy group (n=35, with Endostar combined with chemotherapy) and control group (n=39, with conventional chemotherapy). The recent efficacy of drug was evaluated according to the RECIST criteria. The quality of life (QOL) was assessed by usingto the Karnofsky scores, and the safety of drug was evaluated according to WHO side effects criteria. Results The therapeutic effectiveness was better in the combined therapy group than that in the control group(P<0.01). The KPS was better in co-therapy group than that in the control group(P<0.05). The common adverse reactions in both groups included neutropenia, thrombocytopenia, nausea/vomiting, diarrhea, lassitude, alopecia, thrombocytopenia and leukocytopenia. However, the incidence rates of adverse reactions between the two group was not significant (P>0.05). Conclusion Endostar combined with the related chemotherapy may improve the curative effect and QOL of NSCLC.
论著

玻璃体腔内注射康柏西普治疗湿性老年性黄斑变性对视网膜神经纤维厚度的影响观察

Observation of the thickness on the retinal nerve fiber after treating with wet age-related macular degeneration by adopted intravitreal injection with Conbercept.

:57-60
 
目的 观察康柏西普玻璃体腔注射治疗湿性老年性黄斑变性病变对于视网膜神经纤维厚度的影响。方法 对2016年10月—2017年10月在汕头大学附属韶关市粤北人民医院采用康柏西普玻璃体腔注射治疗湿性老年性黄斑变性35例38眼中符合标准的患者18例(18眼)的临床资料进行回顾性分析,患者行最佳矫正视力、眼压(NCT)检查、OCT、荧光眼底血管造影(FFA)检查后,均接受0.05 mL康柏西普玻璃体腔注射,分别注射后1和2月观察患者最佳矫正视力 (BCVA)、视网膜神经纤维厚度(RNFL)变化。结果 18眼共接受康柏西普玻璃体腔注射54次,所有患眼均注射3次。注射3个月后,OCT检查结果显示有18眼视力有提高,CRT厚度有下降。第1次注射时和注射后1个月、2个月的BCVA分别为0.1(0.04,0.12),0.20(0.10,0.30)和0.25(0.12,0.30),总体比较差异有统计学意义(χ2=13.880,P<0.001);第1次注射时和注射后1个月、2个月的CRT(μm) 319.50(269.50,390.50), 271.00(219.00,296.25) 和234.50(182.75,273.25)总体比较差异有统计学意义(χ2=11.978,P<0.05),第1次注射时和注射后1个月、2个月后的 ARNFL(μm)86.00(76.25,98.00) 83.00(76.00,95.50)和 83.00(76.25,94.75) 总体比较差异无统计学意义(χ2=11.978,P>0.05),第1次注射时和注射后1个月、2个月眼压(kPa)2.27(1.97,2.44),16.0(13.7,17.0),和 2.00(1.84,2.31) 总体比较差异无统计学意义(χ2=1.604,P>0.05)。结论 玻璃体腔注射康柏西普治疗湿性老年性黄斑变性对视网膜神经纤维厚度无明显的损害,安全且有效,但仍需要大样本量及长期随访观察。
Objective To observe the effect on the thickness of retinal nerve fibers in the patients with wet age-related macular degeneration by adopted intravitreal injection with Conbercept. Methods We analyzed 18 cases (18 eyes) that conform to the standard from 35 cases(38 eyes) retrospectively,who were treated with wet age-related macular degeneration by adopted intravitreal injection with Conbercept in Shaoguan Yuebei People's Hospital Affiliated to Shantou University from October in 2016 to October in 2017.After undergoing best corrected visual acuity (BCVA),intraocular pressure (IOP) and fluorescein angiography (FFA),all of them were adopted intravitreal injection with 0.05mL Conbercept. We observed the changes of best corrected visual acuity (BCVA) and retinal nerve fiber thickness (RNFL) after 1 and 2 months of adopted intravitreal injection with 0.05 mL Conbercept. Results 18 eyes were adopted intravitreal injection Conbercept 54 times totally. All the eyes were injected three times. After 3 months of injection,OCT showed that the visual acuity of 18 eyes improved and the thickness of CRT decreased. The BCVA values at the first injection,after the first injection and after the second injection were 0.1(0.04,0.12),0.20(0.10,0.30)和0.25(0.12,0.30)respectively. The overall difference was statistically significant (χ2=13.880,P< 0.001). CRT(μm)values at the first injection,after the first injection and after the second injection were 319.50(269.50,390.50),271.00(219.00,296.25) and 234.50(182.75,273.25)respectively. The overall difference was statistically significant (χ2=11.978,P< 0.05). ARNFL(μm)values at the first injection,after the first injection and after the second injection were 86.00(76.25,98.00),83.00(76.00,95.50) and 83.00(76.25,94.75)respectively. There was no significant difference (χ2=11.978,P> 0.05). The IOP(mmHg)values at the first injection,after the first injection and after the second injection were 17.0(14.8,18.3),16.0(13.7,17.0),和 15.0(13.8,17.3)respectively. There was no significant difference(χ2=1.604,P>0.05). Conclusion There was no obvious damage to the retinal nerve fiber by adopted intravitreal injection with Conbercept to treat the patients with wet age-related macular degeneration. That’s safe and effective,but need a large sample to follow-up for a longtime.
论著

高龄患者腹股沟嵌顿疝术后肺部感染的相关因素分析

Case-control study on correlation factors of inguinal incarcerated hernia surgery related lung infection in elderly patients

:44-48
 
目的 探讨高龄患者(≥65岁)腹股沟嵌顿疝术后肺部感染的相关因素。方法 以我院手术治疗的60例腹股沟嵌顿疝术后肺部感染的高龄患者为观察组,行1∶1匹配病例对照研究,应用单因素及多因素条件Logistic回归对相关因素进行分析,计算各因素与肺部感染的OR值及其95%可信区间。结果 研究提示术前血清白蛋白≤35 g/L(P=0.013)、术前血红蛋白≤100 g/L(P=0.029)、既往慢性阻塞性肺气肿病史(P=0.014)及抽烟(P=0.008)、手术时间≥2 h(P=0.021)、手术切除部分肠管(P=0.032)、气管插管(P=0.024)、手术季节为冬季(P=0.030)为危险因素;预防性使用抗生素(P=0.018)、术后雾化(P=0.023)、良好睡眠(P=0.048)为保护因素。结论 高龄患者腹股沟嵌顿疝术后肺部感染的发生与相关生化指标、既往史、治疗过程、环境因素等密切相关。
Objective To investigate the correlation factors of elderly patients with inguinal incarcerated hernia surgery related lung infection. Methods A hospital-based 1∶1 matched case-control study was conducted among elderly patients with inguinal incarcerated hernia surgery related lung infection,calculated the factors associated with the extent of lung infection,and the 95% confidence interval. Results The analysis showed that pre-ALB≤35g/L(P=0.013),pre-Hb≤100g/L(P=0.029),COPD(P=0.014),smoking(P=0.008),operation time(P=0.021),bowel resection(P=0.032),endotracheal intubation(P=0.024) and operation in winter(P=0.030) were the risk factors of lung infection,while the prophylactic use of antibiotics(P=0.018),aerosol inhalation(P=0.023) and good sleep(P=0.048) were the protective factors. Conclusion Some biochemical indicators,past history,therapeutic process and environmental factors were closely related to inguinal incarcerated hernia surgery related lung infection in elderly patients.
论著

肺保护性通气策略对肺功能不全胃肠手术患者术后转归影响

Effect of lung protective ventilation strategy on postoperative outcome of patients with pulmonary insufficiency of gastrointestinal surgery

:16-20
 
目的 观察肺保护性通气策略对肺功能不全胃肠手术患者术后转归影响。方法 选取2016年4月—2017年3月期间我院收治的90例肺功能不全胃肠手术患者作为研究对象,根据随机数字表将患者随机分为观察组和对照组,每组各45例。对照组采用传统机械通气方式,观察组采用肺保护性通气方式。观察两组患者动脉血气指标、自主呼吸恢复时间、清醒时间、拔管时间、PACU观察时间及住院期间术后肺部并发症发生情况。结果 两组患者麻醉时间、手术时间、晶胶液输入情况、麻醉药物用量差异无统计学意义(P>0.05)。观察组患者术后PaO2高于对照组,差异有统计学意义(P<0.05)。两组患者自主呼吸恢复时间、清醒时间、拔管时间、PACU观察时间比较,差异均无统计学意义(P>0.05)。观察组患者住院期间PPCs发生率低于对照组,差异有统计学意义(P<0.05)。结论 肺保护性通气策略可有效改善肺功能不全胃肠手术患者术后氧合,降低患者住院期间PPCs发生率,对于患者术后转归具有积极的作用。
Objective To observe the effect of lung protective ventilation strategy on postoperative outcome of patients with pulmonary insufficiency of gastrointestinal surgery. Methods 90 patients with pulmonary insufficiency gastrointestinal surgery in our hospital from April 2016 to March 2017 were selected as study subjects. According to the random number table,patients were randomly divided into observation group and control group,with 45 cases in each group. The control group used traditional mechanical ventilation,and the observation group used lung protective ventilation. Arterial blood gas parameters,spontaneous breathing recovery time,awakening time,extubation time,PACU observation time and postoperative pulmonary complications in both groups were observed. Results There was no significant difference in anesthesia time,operation time,crystal glue fluid input,and anesthetic drug dosage between the two groups (P>0.05). The postoperative PaO2 was higher in the observation group than in the control group (P<0.05). There was no significant difference between the two groups in spontaneous breathing recovery time,awakening time,extubation time,and PACU observation time (P>0.05). The incidence of PPCs was lower in the observation group than that in the control group,and the difference was statistical difference (P<0.05). Conclusion Lung protective ventilation strategy may effectively improve postoperative oxygenation in patients with pulmonary insufficiency and gastrointestinal surgery,reduce the incidence of PPCs during hospitalization,and have a positive effect on postoperative outcome.
临床诊疗

血清ApoA-1浓度在食管鳞状上皮细胞癌预后的价值

Value of serum ApoA-1 concentration in prognosis of esophagus squamous cells

:113-115
 
目的 探讨血清ApoA-1浓度与食管鳞状上皮细胞癌的相关性及其预后价值。方法 对我院2010年1月—2012年10月收治的食管鳞状上皮细胞癌患者的血清ApoA-1浓度进行回顾性调查分析,与我院体检中心2009年1月—2009年4月219例正常人群的血清ApoA-1浓度作为对照组进行统计学处理分析。结果 210例食管鳞状上皮细胞癌患者组和219例健康对照组在性别和年龄比较均无统计学差异(P>0.05)。血清ApoA-1 浓度在ESCC组的pTNM和临床分期均有统计学差异(P<0.05)。与ApoA-1水平高的患者相比,ApoA-1水平低的患者的总体生存率更低(P=0.002)。结论 血清ApoA-1 水平是食管鳞状上皮细胞癌食管癌的一个重要的预后因素。
临床诊疗

肺表面活性物质联合高频振荡通气治疗新生儿呼吸窘迫综合征的疗效

Pulmonary surfactant combined with high frequency ventilation in treatment of neonatal respiratory distress syndrome

:94-96
 
目的 探究肺表面活性物质联合高频振荡通气治疗新生儿呼吸窘迫综合征的有效性及安全性。方法 选取我院新生儿科2016年2月—2018年7月收治的120例呼吸窘迫综合征新生患儿作为研究对象,随机将其分为常规组和试验组,每组各60例。常规组实施肺表面活性物质联合常频振荡通气治疗,试验组采取肺表面活性物质联合高频振荡通气治疗,比较两组治疗前后的肺氧合功能和并发症发生情况。结果 PaO2、OI、a/A PO2等指标在治疗前两组差异无统计学意义(P>0.05),治疗后试验组均要优于常规组,差异有统计学意义(P<0.05);常规组的并发症发生率为35.0%(21/60),试验组的并发症发生率为18.3%(11/60),试验组低于常规组,差异有统计学意义(P<0.05)。结论 新生儿呼吸窘迫综合征采用肺表面活性物质联合高频振荡通气治疗效果显著,并发症少,安全性高。
出版者信息








《广州医药》公众号